Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Gaohong Dong

24-Month Safety and Efficacy of Concentration Controlled Everolimus with Reduced Cyclosporine Versus Mycophenolate Mofetil in 721 De Novo Heart Transplant Recipients: Results from the A2310 Study

A Bayesian-frequentist two-stage single-arm phase II clinical trial design

scientific article published on 13 March 2012

A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components

scientific article published on 2 August 2016

A modified varying-stage adaptive phase II/III clinical trial design

scientific article

A varying-stage adaptive phase II/III clinical trial design ⬇️

scientific article published on November 6, 2013

Adjusting win statistics for dependent censoring

scientific article published on 28 November 2020

Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial

scientific article published on 11 September 2013

Cardiovascular Events with De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study

Correlation Between Lipid Levels and Cardiovascular Events in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study

Delayed Introduction of Everolimus Versus Tacrolimus in de Novo Liver Transplant Recipients: Safety Events of Interest with Everolimus Use

Different Methods for Imputing Missing Renal Function Data: Evidence From a Large Clinical Trial in Renal Transplant Recipients

article

Do patient characteristics influence efficacy and renal outcomes in liver transplant patients receiving everolimus?

scientific article published on 30 December 2015

Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation

scientific article published on February 2017

Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial

scientific article published on 13 September 2011

Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation.

scientific article

Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation

scientific article published on 26 March 2012

Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial

scientific article

Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients

Fibrosis progression in maintenance liver transplant patients with hepatitis C recurrence: a randomised study of everolimus vs. calcineurin inhibitors

scientific article published on November 2014

Impact of De Novo Everolimus-Based Immunosuppression on Incisional Complications in Heart Transplantation

scientific article published on 01 September 2011

Meta-Analysis for Rare Events As Binary Outcomes

Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study

scientific article

Some Characteristics of the Varying-Stage Adaptive Phase II/III Clinical Trial Design

TRANSFORM: a novel study design to evaluate the effect of everolimus on long-term outcomes after kidney transplantation

article by Julio Pascual et al published June 2014 in Open Access Journal of Clinical Trials

The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring

scientific article published on 17 June 2020

The stratified win ratio

scientific article published on 27 November 2017

The win ratio: Impact of censoring and follow-up time and use with nonproportional hazards

scientific article published on 31 October 2019

Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study

scientific article

Paulina is supported by:

About Paulina

Help